title: Pharmaceuticals issue brief: narrow therapeutic index drugs.
abstract: How have state legislatures grappled with the twin issues of safety and generic substitution for narrow therapeutic index (NTI) drugs (which can be lethal when taken in less than twice the prescribed dosage)?
authors.forename: C
authors.initials: C
authors.lastname: Hackney
mesh_terms: D011307:Drug Prescriptions; D004363:Drug Utilization / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000627:therapeutic use; D006801:Humans; D019458:Insurance Coverage / Q000331:legislation & jurisprudence; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence*; D007928:Lethal Dose 50; D013219:State Government; D013810:Therapeutic Equivalency; D014481:United States
chemical_list: D016568:Drugs, Generic